|
|
|
Insider
Information: |
Dixon Richard A F |
Relationship: |
Sr. VP Research & CSO,... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Encysive Pharmaceuticals Inc |
ENCY |
Sr. VP Research & CSO,... |
2008-04-01 |
0 |
2003-07-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2008-04-01 |
4 |
D |
$2.35 |
$1,065,723 |
D/D |
(453,499) |
0 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2007-12-11 |
4/A |
A |
$0.00 |
$0 |
D/D |
125,000 |
453,499 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2007-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
390,999 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2007-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
43,573 |
328,499 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2006-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
28,249 |
284,926 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2005-08-10 |
4 |
S |
$12.00 |
$18,864 |
D/D |
(1,572) |
256,677 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2005-08-08 |
4 |
OE |
$4.38 |
$319,375 |
D/D |
73,000 |
258,249 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2005-08-08 |
4 |
S |
$12.00 |
$857,136 |
D/D |
(71,428) |
256,677 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,688 |
256,677 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2004-05-06 |
4 |
OE |
$0.93 |
$215,853 |
D/D |
152,100 |
251,989 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2004-05-06 |
4/A |
OE |
$1.47 |
$58,800 |
D/D |
40,000 |
214,889 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2004-05-06 |
4 |
S |
$9.56 |
$716,918 |
D/D |
(75,000) |
214,889 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2004-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,178 |
174,889 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2003-12-22 |
4 |
D |
$7.28 |
$200,943 |
D/D |
(27,602) |
169,711 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2003-12-22 |
4 |
OE |
$5.30 |
$200,948 |
D/D |
37,815 |
190,823 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2003-07-07 |
4 |
S |
$4.71 |
$97,696 |
D/D |
(20,729) |
159,498 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2003-07-07 |
4 |
OE |
$3.50 |
$72,552 |
D/D |
20,729 |
180,227 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2003-07-03 |
4 |
S |
$4.95 |
$3,465 |
D/D |
(700) |
159,498 |
|
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Sr. V.P. Research & CSO |
|
2003-07-03 |
4 |
OE |
$3.50 |
$2,450 |
D/D |
700 |
160,198 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|